Infection of astrocytes by a virus isolated from CSF cells of an HIV-positive patient virologically suppressed with ART

Infection of astrocytes by a virus isolated from CSF cells of an HIV-positive patient virologically suppressed with ART

Bibliographic Details
Main Authors:	G. Li, B. Smith, H. Imamichi, L. Henderson, S. Steinbach, C. Lane, A. Nath
Format:	Article
Language:	English
Published:	Elsevier 2017-12-01
Series:	Journal of Virus Eradication
Online Access:	http://www.sciencedirect.com/science/article/pii/S2055664020306221

Similar Items

HIV isolated from CSF cells of a virologically controlled patient infects astrocytes
by: G.H. Li, et al.
Published: (2015-12-01)

CXCR4-usage HIV-1 strains isolated from blood and cerebrospinal fluid in subjects on suppressive antiretroviral therapy
by: A. Nath, et al.
Published: (2019-12-01)

Antiretroviral adherence and virologic suppression in partnered and unpartnered HIV-positive individuals in southern Brazil.
by: Marineide Gonçalves de Melo, et al.
Published: (2019-01-01)

Discordant Liver Fibrosis Predictors in Virologically Suppressed People Living with HIV without Hepatitis Virus Infection
by: Barbara Rossetti, et al.
Published: (2021-12-01)

Dysregulation of iron metabolism modulators in virologically suppressed HIV-infected patients
by: Vanesa Garrido-Rodríguez, et al.
Published: (2022-11-01)

HIV Nurse Navigation: Charting the Course to Improve Engagement in Care and HIV Virologic Suppression
by: Octaviana Hemmy Asamsama PsyD, et al.
Published: (2017-11-01)

HIV-Associated Neurocognitive Impairment in the Modern ART Era: Are We Close to Discovering Reliable Biomarkers in the Setting of Virological Suppression?
by: Alessandra Bandera, et al.
Published: (2019-08-01)

How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy
by: Anthony Jaworowski, et al.
Published: (2019-06-01)

Clinical effects of durability of immunosuppression in virologically suppressed ART-initiating persons with HIV in Latin America. A retrospective cohort study
by: Yanink Caro-Vega, et al.
Published: (2022-04-01)

O8 Cell-associated HIV-1 unspliced RNA level predicts both time to virological suppression and duration of post-treatment virological control in patients treated with temporary early ART
by: Alexander Pasternak, et al.
Published: (2016-09-01)

Virologic suppression in response to antiretroviral therapy despite extensive resistance within HIV-1 reverse transcriptase after the first virologic failure
by: Marta Iglis Oliveira, et al.
Published: (2018-10-01)

Increased CMV IgG Antibody Titer is Associated with Non-AIDS Events Among Virologically Suppressed HIV-Positive Persons
by: Aimee Hodowanec, et al.
Published: (2019-02-01)

Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014–July 2015
by: Lilian Bulage, et al.
Published: (2017-05-01)

Baseline adherence, socio-demographic, clinical, immunological, virological and anthropometric characteristics of 242 HIV positive patients on ART in Malaysia
by: Abiola, Abdulrahman Surajudeen, et al.
Published: (2015)

Early virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
by: Prendergast, A, et al.
Published: (2008)

Peripheral Neuropathy in Virologically Suppressed People Living with HIV: Evidence from the PIVOT Trial
by: Anna L. Schuldt, et al.
Published: (2023-12-01)

Sex-related differences in markers of immune activation in virologically suppressed HIV-infected patients
by: Letizia Santinelli, et al.
Published: (2020-05-01)

Monocyte bioenergetic function is associated with body composition in virologically suppressed HIV-infected women
by: Amanda L. Willig, et al.
Published: (2017-08-01)

Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration.
by: Giota Touloumi, et al.
Published: (2013-01-01)

T cell derived HIV-1 is present in the CSF in the face of suppressive antiretroviral therapy.
by: Gila Lustig, et al.
Published: (2021-09-01)

OA2-2 Cell-associated HIV-1 unspliced RNA level predicts both time to virological suppression and duration of post-treatment virological control in patients treated with temporary early ART
by: A. Pasternak, et al.
Published: (2016-07-01)

Determinants of restoration of CD4 and CD8 cell counts and their ratio in HIV-1 positive individuals with sustained virological suppression on antiretroviral therapy
by: Gras, L, et al.
Published: (2018)

The Association of Meningitis with Altered Sensorium and CSF Inflammation in HIV-Positive Patients
by: Sridhar Amalakanti, et al.
Published: (2023-11-01)

Combination anti‐HIV antibodies to achieve antiretroviral therapy‐free virological suppression in infected individuals
by: M. Ali Rai, et al.
Published: (2022-09-01)

Long-term outcome of lamivudine/dolutegravir dual therapy in HIV-infected, virologically suppressed patients
by: Franco Maggiolo, et al.
Published: (2022-10-01)

Budget impact analysis in the maintenance raltegravir-containing regimen in virologically suppressed HIV infected patients
by: Roberto Ravasio, et al.
Published: (2017-07-01)

Efficacy and safety of switching from branded to generic antiretrovirals in virologically suppressed HIV-infected patients.
by: Nicola Gianotti, et al.
Published: (2017-01-01)

Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
by: Mulugeta Melku, et al.
Published: (2020-08-01)

Current ART, determinants for virologic failure and implications for HIV drug resistance: an umbrella review
by: SeyedAhmad SeyedAlinaghi, et al.
Published: (2023-10-01)

Acute HIV infection presenting as hemophagocytic syndrome with an unusual serological and virological response to ART
by: Rita Veiga Ferraz, et al.
Published: (2016-10-01)

Genotyping and virological characteristics of hepatitis B virus in HIV-infected individuals in Sudan
by: Mukhlid Yousif, et al.
Published: (2014-12-01)

State-of-the-Art Virology Research in Norway
by: Christine Hanssen Rinaldo, et al.
Published: (2023-12-01)

Virological Non-Suppression among Newly Diagnosed HIV-Positive Individuals on Dolutegravir-Based Antiretroviral Treatment in Eastern Ethiopia: Follow-Up Study
by: Abdella Gemechu, et al.
Published: (2023-07-01)

First-line virologic-based ART treatment failure and associated factors among adult HIV Positives in Southwest Shoa, Central Ethiopia
by: Diriba Mulisa (Bsc,Msc in Adult Health Nursing), et al.
Published: (2022-07-01)

Prevalence, clinical and virologic outcomes of hepatitis B virus co-infection in HIV-1 positive Kenyan women on antiretroviral therapy.
by: Summer L Day, et al.
Published: (2013-01-01)

Recruitment of Youth Living With HIV to Optimize Adherence and Virologic Suppression: Testing the Design of Technology-Based Community Health Nursing to Improve Antiretroviral Therapy (ART) Clinical Trials
by: Agwu, Allison Lorna, et al.
Published: (2020-12-01)

Immune markers, diurnal blood pressure profile and cardiac function in virologically suppressed HIV-infected patients
by: Ingjerd W. Manner, et al.
Published: (2017-11-01)

The risk of virologic failure decreases with duration of HIV suppression, at greater than 50% adherence to antiretroviral therapy.
by: Michael Rosenblum, et al.
Published: (2009-09-01)

Durable Suppression of HIV-1 after Virologic Monitoring-Based Antiretroviral Adherence Counseling in Rakai, Uganda.
by: Alexander Billioux, et al.
Published: (2015-01-01)

Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)
by: Florian Liégeois, et al.
Published: (2020-01-01)